Aegerion Pharma CEO and COO Bid Adieu - Stock Market News & Financial Analysis -BoardProspects

Aegerion Pharma CEO and COO Bid Adieu

Stock Market News & Financial Analysis Jul 27 2015 BoardNews

Aegerion Pharmaceuticals (NASDAQ:AEGR) CEO Marc Beer and COO Craig Fraser resign. Board member Sandford Drexel Smith takes over as interim CEO until a permanent successor is hired. The stock is still mired in a long-term downtrend. Shares are down ~83% from the peak of $101 in late 2013...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Corporate Boards: Shifting From Aging Men To New Generation Of Women? also categorized in BoardNews
- Facebook's Board Reveals 2 Major Flaws also published in Stock Market News & Financial Analysis
- Ultrapetrol: A Case Study On Questionable Corporate Governance also published in Stock Market News & Financial Analysis
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Obagi Files 8k Officially Removing Poison Pill, Clears Way For Acquisition also published in Stock Market News & Financial Analysis
- The Other Duty of Corporate Governance also categorized in BoardNews
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- Microsoft CEO to Retire Within 12 Months also mentions CEO
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
Topics Mentioned
- CEO